In an attempt to understand the multifunctional involvement of β2-glycoprotein I (β2GPI) in
autoimmune diseases, thrombosis, atherosclerosis, and inflammatory processes, substantial …

Complexes formed between β2GPI (β2-glycoprotein I), a human plasma protein, and
biological membranes are considered to be targets of macrophages and antiphospholipid …

The high affinity of human plasma β2‐glycoprotein I (β 2 GPI), also known as apolipoprotein‐
H (ApoH), for negatively charged phospholipids determines its implication in a variety of …

Human β2-glycoprotein I is a heavily glycosylated plasma protein which has been
implicated in the binding of antiphospholipid antibodies to negatively charged …

β2-Glycoprotein I (β2-GPI) is a plasma protein that binds to negatively charged substances
such as DNA, heparin, and anionic phospholipids. The interaction of β2-GPI with anionic …

The plasma protein β 2-glycoprotein I (β 2-GPI) is a major target of autoantibodies in patients
with the antiphospholipid syndrome. To understand the physiological function of β 2-GPI and …

Considerable interest is currently focused on the interactions of beta-2 glycoprotein I (β2GPI)
and anti-phospholipid antibodies with anionic phospholipids in an attempt to understand the …

To understand the mechanism of the interaction between human β2-glycoprotein I (β2-GPI)
and negatively charged phospholipids, we determined the three-dimensional solution …

Summary β 2‐Glycoprotein I (β 2‐GPI) is a protein that circulates in blood at high
concentrations. The function of β 2‐GPI has long been an enigma. More than 20 years ago …

Abstract “Antiphospholipid” autoantibodies are associated with arterial and venous
thrombosis, recurrent fetal loss, and thrombocytopenia. At present, the best-characterized …